β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease. (Q51696941)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 June 2016

Language	Label	Description	Also known as
English	β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease.	scientific article published on 17 June 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Shreesh Ojha

1

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

Hayate Javed

2

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

Sheikh Azimullah

3

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

M Emdadul Haque

4

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

publication date

17 June 2016

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

Molecular and Cellular Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

418

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

1-2

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

59-70

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

Understanding Parkinson Disease: A Complex and Multifaceted Illness

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Etiology and pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Pathogenesis-targeted, disease-modifying therapies in Parkinson disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

The emerging role of nutrition in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models?

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Phytocannabinoids as novel therapeutic agents in CNS disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Beta-caryophyllene is a dietary cannabinoid

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Quantitative structure-activity relationship (QSAR) for neuroprotective activity of terpenoids

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

β-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

β-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1/PGC-1α pathway

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Activation of cannabinoid CB2 receptor-mediated AMPK/CREB pathway reduces cerebral ischemic injury.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Neuroprotective effects of trans-caryophyllene against kainic acid induced seizure activity and oxidative stress in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Trans-caryophyllene suppresses hypoxia-induced neuroinflammatory responses by inhibiting NF-κB activation in microglia

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

β-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

A highly reproducible rotenone model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Effect of sesamin in Acanthopanax senticosus HARMS on behavioral dysfunction in rotenone-induced parkinsonian rats.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Selective microglial activation in the rat rotenone model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Interaction of aldehydes derived from lipid peroxidation and membrane proteins

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Cellular and molecular mechanisms of antioxidants in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Effects of natural antioxidants in neurodegenerative disease.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Glutathione metabolism and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Antigenotoxic capacity of beta-caryophyllene in mouse, and evaluation of its antioxidant and GST induction activities

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Virtual screening and in vitro assay of potential drug like inhibitors from spices against Glutathione-S-Transferase of Meloidogyne incognita

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Rotenone-induced neurotoxicity in rat brain areas: a study on neuronal and neuronal supportive cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Glial reactions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2733-Y

21 January 2018

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27316720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age related interaction of dopamine and serotonin synthesis in striatal synaptosomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/27316720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic potential of natural products in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27316720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27316720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11010-016-2733-Y

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/27316720

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51696941&oldid=2211095288"